775 results on '"Siest, Gérard"'
Search Results
2. Dairy product consumption, calcium intakes, and metabolic syndrome–related factors over 5 years in the STANISLAS study
3. A common variant highly associated with plasma VEGFA levels also contributes to the variation of both LDL-C and HDL-C
4. Next generation sequencing and immuno-histochemistry profiling identify numerous biomarkers for personalized therapy of endometrioid endometrial carcinoma
5. Clinical necessity of partitioning of human plasma haptoglobin reference intervals by recently-discovered rs2000999
6. Differential Susceptibility of Human Apolipoprotein E Isoforms to Oxidation and Consequences on their Interaction with Phospholipids
7. Age-related variations of enzymatic defenses against free radicals and peroxides
8. Metabolic syndrome-related composite factors over 5 years in the STANISLAS Family Study: Genetic heritability and common environmental influences
9. Premature Discontinuation Of Clinical Trial For Reasons Not Related To Efficacy, Safety, Or Feasibility
10. Adipokine expression in adipose tissue and in peripheral blood mononuclear cells in children: Correlation with BMI and fatty acid content
11. Association of ABCB1 gene polymorphisms with plasma lipid and apolipoprotein concentrations in the STANISLAS cohort
12. High-Level Expression of Enzymatically Active Mature Human γ- Glutamyltransferase in Transgenic V79 Chinese Hamster Cells
13. Statins as effectors of key activities involved in apoE-dependent VLDL metabolism: Review and hypothesis
14. Genetic profiling of human cell lines used as in vitro model to study cardiovascular pathophysiology and pharmacotoxicology
15. Conference Scene: Pharmacogenomics: from cell to clinic (Part 2)
16. Conference Scene: Pharmacogenomics: from cell to clinic (Part 1)
17. Analysis of the effect of multiple genetic variants of cardiovascular disease risk on insulin concentration variability in healthy adults of the STANISLAS cohort: The role of FGB −455 G/A polymorphism
18. Enzymes and pharmacogenetics of cardiovascular drugs
19. Effect of six candidate genes on early aging in a French population
20. Conference Scene: Systems biology and personalized health science and translation
21. The structure of human apolipoprotein E2, E3 and E4 in solution: 1. Tertiary and quaternary structure
22. The structure of human apolipoprotein E2, E3 and E4 in solution. 2. Multidomain organization correlates with the stability of apoE structure
23. Clinical Chemistry and Laboratory Medicine: progress and new challenges for our 50-year-old journal
24. Clinical interest of point-of-care pharmacogenomic testing: clopidogrel behind warfarin
25. Pharmacogenomics and Cardiovascular Drugs
26. Availability of pharmacogenetic and pharmacogenomic information in anticancer drug monographs in France: personalized cancer therapy
27. Functional genomics towards personalized healthcare and systems medicine
28. Polymorphism of the 5-HT2A receptor gene and food intakes in children and adolescents: the Stanislas Family Study
29. Increasing laboratory medicine activities in China: research and publications
30. Personalized therapy and pharmacogenomics: future perspective
31. Human formyl peptide receptor 1 (FPR1) c.32C>T SNP is associated with decreased soluble E-selectin levels
32. Genetic and environmental contributions to serum retinol and α-tocopherol concentrations: the Stanislas Family Study
33. Systems biology and personalized prevention
34. Parental precocious influences on offspring cardiovascular risk markers: an exploratory study in the STANISLAS Cohort
35. Functional genomics towards personalized healthcare
36. Pharmacogenomics and cardiovascular drugs: Need for integrated biological system with phenotypes and proteomic markers
37. CCLM Award for the most cited paper recently published
38. CCLM: Evolving to meet the needs of todayʼs laboratory professionals and scientists
39. The STANISLAS Cohort: a 10-year follow-up of supposed healthy families. Gene-environment interactions, reference values and evaluation of biomarkers in prevention of cardiovascular diseases
40. Pharmacy-based laboratory services: past or future and risk or opportunity?
41. Genetic profiling in healthy subjects from the Stanislas cohort based on 24 polymorphisms: effects on biological variables
42. Pharmacogenomics and antihypertensive drugs: a path toward personalized medicine
43. Association of classical and related inflammatory markers with high-sensitivity C-reactive protein in healthy individuals: results from the Stanislas cohort
44. EDITORIAL
45. Determination of ABCB1 polymorphisms and haplotypes frequencies in a French population
46. Third Santorini conference pharmacogenomics workshop report: “Pharmacogenomics at the crossroads: what else than good science will be needed for the field to become part of Personalized Medicine?”
47. Compared Effect of Immunosuppressive Drugs Cyclosporine A and Rapamycin on Cholesterol Homeostasis Key Enzymes CYP27A1 and HMG-CoA Reductase
48. From human genetic variations to prediction of risks and responses to drugs and the environment: Meeting report on the third “Biologie Prospective” Santorini conference, September 29-October 2, 2006, Santorini Island, Greece
49. From human genetic variations to prediction of risks and responses to drugs and the environment: 3rd ‘Biologie Prospective’ Santorini Conference, September 29-October 2, 2006, Santorini Island, Greece
50. Genetic and environmental contributions to serum ascorbic acid concentrations: the Stanislas Family Study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.